Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

January 01, 2001; Volume 29,Issue 1

Short Communications

  • You have access
    P450 Interaction with HIV Protease Inhibitors: Relationship between Metabolic Stability, Inhibitory Potency, and P450 Binding Spectra
    Masato Chiba, Lixia Jin, William Neway, Joseph P. Vacca, James R. Tata, Kevin Chapman and Jiunn H. Lin
    Drug Metabolism and Disposition January 2001, 29 (1) 1-3;
  • You have access
    Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1
    Jiangjun Sheng, Zichun Hua, Jiancheng Guo, Michele Caggana and Xinxin Ding
    Drug Metabolism and Disposition January 2001, 29 (1) 4-7;

Articles

  • You have access
    Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms
    Nisar A. Pampori, Arun K. Agrawal and Bernard H. Shapiro
    Drug Metabolism and Disposition January 2001, 29 (1) 8-16;
  • You have access
    Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia
    Stephanie R. Mitchell, Marion B. Sewer, Sean S. Kardar and Edward T. Morgan
    Drug Metabolism and Disposition January 2001, 29 (1) 17-22;
  • You have access
    A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry
    Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball
    Drug Metabolism and Disposition January 2001, 29 (1) 23-29;
  • You have access
    Application of Higher Throughput Screening (HTS) Inhibition Assays to Evaluate the Interaction of Antiparasitic Drugs with Cytochrome P450s
    Tashinga E. Bapiro, Ann-Charlotte Egnell, Julia A. Hasler and Collen M. Masimirembwa
    Drug Metabolism and Disposition January 2001, 29 (1) 30-35;
  • You have access
    Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes
    Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba
    Drug Metabolism and Disposition January 2001, 29 (1) 36-40;
  • You have access
    Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6
    Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders
    Drug Metabolism and Disposition January 2001, 29 (1) 41-47;
  • You have access
    Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions
    Brian T. Ethell, Kevin Beaumont, David J. Rance and Brian Burchell
    Drug Metabolism and Disposition January 2001, 29 (1) 48-53;
  • You have access
    The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers
    Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim
    Drug Metabolism and Disposition January 2001, 29 (1) 54-59;
  • You have access
    Metabolism of [14C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans
    Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani
    Drug Metabolism and Disposition January 2001, 29 (1) 60-69;
  • You have access
    Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site
    Michael L. Schrag and Larry C. Wienkers
    Drug Metabolism and Disposition January 2001, 29 (1) 70-75;
  • You have access
    Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment
    Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos
    Drug Metabolism and Disposition January 2001, 29 (1) 76-81;
  • You have access
    Development of an in Vivo Preclinical Screen Model to Estimate Absorption and Bioavailability of Xenobiotics
    Keith W. Ward, Joel W. Proksch, Mark A. Levy and Brian R. Smith
    Drug Metabolism and Disposition January 2001, 29 (1) 82-88;

Erratum

  • You have access
    Correction to “Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan”
    Drug Metabolism and Disposition January 2001, 29 (1) 89;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 29 (1)
Drug Metabolism and Disposition
Vol. 29, Issue 1
1 Jan 2001
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics